Page 3 - Jenny Barta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novavax COVID-19 Vaccine Candidate Starts Final-Stage Trial In U.S. Public health experts say more options in addition to the two vaccines now being dispensed are critical to amassing enough shots for the country. LAURAN NEERGAARD A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak. Public health experts say more options in addition to the two vaccines now being dispensed — one made by Pfizer and its German partner BioNTech, the other...

AP Medical Writer A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak. Public health experts say more options in addition to the two vaccines now being dispensed — one made by Pfizer and its German partner BioNTech, the other by Moderna — are critical to amassing enough shots for the country and the world. The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the United States. Some 30,000 volunteers are n...

A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak. Public health experts say more options in addition to the two vaccines now being dispensed — one made by Pfizer and its German partner BioNTech, the other by Moderna — are critical to amassing enough shots for the country and the world. The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the United States. Some 30,000 volunteers are needed to prove if ...

More COVID-19 vaccines move into the pipeline as U.S. ramps up effort Updated Dec 28, 2020; Posted Dec 28, 2020 Ellie Basham, Executive Director at Life Care Center in Kirkland, Wash., being vaccinated by Kristine Kim, a pharmacist for CVS outside the Center in Kirkland, Wash., Monday, Dec. 28, 2020. (Steve Ringman/The Seattle Times via AP) AP Facebook Share A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak. Public health experts s...

More coronavirus vaccines are in the pipeline as U.S. effort ramps up A candidate made by Novavax Inc. is the fifth to reach final-stage testing in the United States     Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, prepares to receive his first dose of the COVID-19 vaccine at the National Institutes of Health in Bethesda, Md. [ PATRICK SEMANSKY | AP ] Published Dec. 28, 2020 A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awai...